Class Action Reminder: ATYR Investors Should Contact Robbins LLP for Information About Leading the aTyr Pharma, Inc. Class Action Lawsuit
Company: aTyr Pharma, Inc. (NASDAQ: ATYR) is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. https://mma.prnewswire.com/media/1321386/Robbins_LLP_Logo.jpg Class Period: January 16, 2025 – September 12, 2025 The Case: Robbins LLP reminds stockholders that a class action was filed on behalf of aTyr Pharma, Inc. […]